1-[(2,6- dimethylphenyl) aminocarbonylmethyl piperazine [5294-61-1]

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes citicoline tablets 200 mg/ 500 mg/ 750 mg/ 1000 mg. It belongs to central nervous system finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes [(2,6- dimethylphenyl) aminocarbonylmethyl]-chloride [1311-01-7]. It belongs to ranolazine intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes [1-hydroxy-2-(3-pyridinyl) ethylidene]-biphosphonic acid [105462-24-6]. It belongs to risedronate sodium intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes [1,1'-biphenyl]-2-carbonitrile-4-[(2-butyl-4-oxo-1,3-diazaspiro [4.4]-non- 1-en-3-yl)- methyl]. It belongs to irbesartan intermediates products category. Contact us for more informat...

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes [138401-24-8]. It belongs to irbesartan intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 1- (2-methoxyphenoxy) -2,3-epoxypropane. [2210-74-4]. It belongs to ranolazine intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 2- thiazine-1,1-dioxide. Cas no : 70417-50-8. It belongs to lornoxicam intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 2-(1-adamantyl)-4-bromophenol 2-(1-adamantyl) -4-bromoanisole [104224-63-7]. It belongs to adapalene intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 2-chloro-1, 3-bis (dimethylamino)-trimethinium hexafluorophosphate. It belongs to etoricoxib intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 2-n butyl-3-[(2-cyanobiphenyl-4-yl) methyl]-1,3-diazaspiro [4,4] non-1-en-4-one. It belongs to irbesartan intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-1h-benzimidazole [152628-02-9]. It belongs to telmisartan intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 2-n-propyl-4-methyl-6(1-methyl benzemidazole-2yl) benzomidazole. It belongs to telmisartan intermediates products category. Contact us for more information.

Dharmesh Shah, Chairman & Managing Director of BDR Pharmaceuticals, speaks with CPHI TV at CPHI Worldwide in Madrid.